why did the fda ban tirzepatide U.S. Food and Drug Administration is moving toward allowing compounding pharmacies ⁠to produce more than a dozen injectable peptides that were banned because of ⁠potentially significant safety risks, the New York Did the FDA Ban Compounded

However, NAC clinical studies have not been consistent

State licensure of the prescribing clinician

It is critical to understand the difference between compounded and brand-name GLP-1 medications: Brand-name medications (Wegovy, Zepbound) are FDA-approved, manufactured under strict quality controls, and have been tested in large-scale clinical trials Compounded versions are not FDA-approved, meaning they have not undergone the same safety and efficacy testing In 2025, the FDA declared the shortage over, meaning compounding of semaglutide and tirzepatide is no longer legally permitted for most pharmacies Some compounded products have used different salt forms of semaglutide (such as semaglutide acetate instead of semaglutide sodium) that have not been shown to behave identically in the body Who Is a Good Candidate for GLP-1 Weight Loss Medication

Understanding the science behind subcutaneous injections can help you feel more confident in your routine and may even help you manage potential side effects more effectively

Pens either deliver one fixed dose, or they can be dialed to the appropriate dose and work right away

Gallbladder Problems: Ozempic may increase the risk of gallbladder problems